Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.

BACKGROUND & AIMS Celiac disease is characterized by activation of HLA-DQ2/DQ8-restricted intestinal gluten-specific CD4(+) T cells. In particular, gluten becomes a better T-cell antigen following deamidation catalyzed by tissue transglutaminase. To date, the only available therapy is represented by adherence to a gluten-free diet. Here, we examined a new enzyme strategy to preventively abolish gluten activity. METHODS Enzyme modifications of the immunodominant alpha-gliadin peptide p56-68 were analyzed by mass spectrometry, and peptide binding to HLA-DQ2 was simulated by modeling studies. Wheat flour was treated with microbial transglutaminase and lysine methyl ester; gliadin was subsequently extracted, digested, and deamidated. Gliadin-specific intestinal T-cell lines (iTCLs) were generated from biopsy specimens from 12 adult patients with celiac disease and challenged in vitro with different antigen preparations. RESULTS Tissue transglutaminase-mediated transamidation with lysine or lysine methyl ester of p56-68 or gliadin in alkaline conditions inhibited the interferon gamma expression in iTCLs; also, binding to DQ2 was reduced but not abolished, as suggested by in silico analysis. Lysine methyl ester was particularly effective in abrogating the activity of gliadin. Notably, a block in the response was observed when iTCLs were challenged with gliadin extracted from flour pretreated with microbial transglutaminase and lysine methyl ester. CONCLUSIONS Transamidation of wheat flour with a food-grade enzyme and an appropriate amine donor can be used to block the T cell-mediated gliadin activity. Considering the crucial role of adaptive immunity in celiac disease, our findings highlight the potential of the proposed treatment to prevent cereal toxicity.

[1]  Roepstorff,et al.  Identification of a Gliadin T‐Cell Epitope in Coeliac Disease: General Importance of Gliadin Deamidation for Intestinal T‐Cell Recognition , 1998, Scandinavian journal of immunology.

[2]  E. Lindberg,et al.  Oats to children with newly diagnosed coeliac disease: a randomised double blind study , 2004, Gut.

[3]  F. Maurano,et al.  Intravenous or Intranasal Administration of Gliadin is Able to Down‐Regulate the Specific Immune Response in Mice , 1999, Scandinavian journal of immunology.

[4]  C. Collar,et al.  Significance of microbial transglutaminase on the sensory, mechanical and crumb grain pattern of enzyme supplemented fresh pan breads , 2005 .

[5]  P. Roepstorff,et al.  The Intestinal T Cell Response to α-Gliadin in Adult Celiac Disease Is Focused on a Single Deamidated Glutamine Targeted by Tissue Transglutaminase , 2000, The Journal of experimental medicine.

[6]  R. Troncone,et al.  Latest developments in the pathogenesis and treatment of celiac disease. , 2006, The Journal of pediatrics.

[7]  M. Paulsson,et al.  Identification of Gln726 in nidogen as the amine acceptor in transglutaminase-catalyzed cross-linking of laminin-nidogen complexes. , 1992, The Journal of biological chemistry.

[8]  P. Schieberle,et al.  Studies on effects of microbial transglutaminase on gluten proteins of wheat. I. Biochemical analysis , 2003 .

[9]  J. Drijfhout,et al.  The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. , 2002, Gastroenterology.

[10]  P. Roepstorff,et al.  Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. , 2002, Gastroenterology.

[11]  D. Jewell,et al.  In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope , 2000, Nature Medicine.

[12]  C. Gianfrani,et al.  Adaptive and innate immune responses in celiac disease. , 2005, Immunology letters.

[13]  J. E. Folk,et al.  gamma-Glutamylamine cyclotransferase: specificity toward epsilon-(L-gamma-glutamyl)-L-lysine and related compounds. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Greco,et al.  Majority of Gliadin-Specific T-Cell Clones from Celiac Small Intestinal Mucosa Produce Interferon-γ and Interleukin-4 , 2004, Digestive Diseases and Sciences.

[15]  L. Sollid,et al.  Prolyl Endopeptidase-Mediated Destruction of T Cell Epitopes in Whole Gluten: Chemical and Immunological Characterization , 2005, Journal of Pharmacology and Experimental Therapeutics.

[16]  T. Peters,et al.  Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. , 1985, Clinical science.

[17]  K. Lundin,et al.  T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase , 2001, European journal of immunology.

[18]  T. Okita,et al.  Nucleic acid (cDNA) and amino acid sequences of alpha-type gliadins from wheat (Triticum aestivum). , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Thorsby,et al.  Identification of a putative motif for binding of peptides to HLA-DQ2. , 1996, International immunology.

[20]  H. Wieser,et al.  [Comparative studies of the Osborne protein fraction of wheat varieties with different dough and baking properties]. , 1992, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.

[21]  S. Costantini,et al.  Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease. , 2005, Journal of molecular graphics & modelling.

[22]  J. Thornton,et al.  Satisfying hydrogen bonding potential in proteins. , 1994, Journal of molecular biology.

[23]  F. Koning,et al.  Peptide binding characteristics of the coeliac disease-associated DQ(α1*0501, β1*0201) molecule , 2007, Immunogenetics.

[24]  G. Nepom,et al.  HLA-DQ polymorphisms are highly selective for peptide binding interactions. , 1995, Journal of immunology.

[25]  F. Koning,et al.  Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. , 1998, Journal of immunology.

[26]  L. Fugger,et al.  Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease , 1998, Nature Medicine.

[27]  H. Rammensee,et al.  The peptide binding motif of the disease associated HLA‐DQ (α 1* 0501, β 1* 0201) molecule , 1996 .

[28]  L. Sollid,et al.  Gliadin T Cell Epitope Selection by Tissue Transglutaminase in Celiac Disease , 2002, The Journal of Biological Chemistry.

[29]  Lu Shan,et al.  Structural Basis for Gluten Intolerance in Celiac Sprue , 2002, Science.

[30]  H. Wieser,et al.  Investigation of the putative immunodominant T cell epitopes in coeliac disease , 2003, Gut.

[31]  L. Sollid,et al.  Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue. , 2004, The Biochemical journal.

[32]  K. Yasumoto,et al.  Amine-binding capacities of food proteins in transglutaminase reaction and digestibility of wheat gliadin with ε-attached lysine , 1986 .

[33]  R. Troncone,et al.  Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice. , 2003, Immunology letters.

[34]  Hongyi Zhou,et al.  A physical reference state unifies the structure‐derived potential of mean force for protein folding and binding , 2004, Proteins.

[35]  L. Sollid.  Coeliac disease: dissecting a complex inflammatory disorder , 2002, Nature Reviews Immunology.

[36]  L. Fugger,et al.  HLA binding and T cell recognition of a tissue transglutaminase‐modified gliadin epitope , 1999, European journal of immunology.

[37]  F. Maurano,et al.  Immunomodulatory Strategies for Celiac Disease , 2005, International reviews of immunology.

[38]  E. Bergseng,et al.  Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Shan,et al.  Intestinal digestive resistance of immunodominant gliadin peptides. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[40]  K. Lundin,et al.  Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. , 1998, Gastroenterology.

[41]  A. Camarca,et al.  Gliadin-Specific Type 1 Regulatory T Cells from the Intestinal Mucosa of Treated Celiac Patients Inhibit Pathogenic T Cells , 2006, The Journal of Immunology.

[42]  N. Cerf-Bensussan,et al.  Oral proteases: a new approach to managing coeliac disease , 2006, Gut.

[43]  A. Fasano,et al.  Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease , 2000, The Lancet.

[44]  G. Oberhuber,et al.  The histopathology of coeliac disease: time for a standardized report scheme for pathologists. , 1999, European journal of gastroenterology & hepatology.

[45]  K. Yokoyama,et al.  Properties and applications of microbial transglutaminase , 2004, Applied Microbiology and Biotechnology.

[46]  C. Gianfrani,et al.  Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa , 2004, Gut.

[47]  Don C. Wiley,et al.  Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes , 2001, Nature Immunology.